A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent

Details for Australian Patent Application No. 2002351340 (hide)

Owner MERCK AND CO., INC. MERCK SHARP AND DOHME DE ESPANA, S. A.

Inventors Basilio, Angela; Harris, Guy H; Collado, Javier; Guan, Ziqiang; Diez, Maria Teresa; Justice, Michael C; Shastry, Mythili S; Nielsen-Kahn, Jennifer

Agent Spruson & Ferguson

Pub. Number AU-A-2002351340

PCT Number PCT/US02/39411

PCT Pub. Number WO2003/051889

Priority 60/340,367 14.12.01 US

Filing date 10 December 2002

Wipo publication date 30 June 2003

International Classifications

A61K 031/365 - Lactones

A61K 031/335 - having oxygen as the only ring hetero atom, e.g. fungichromin

C07D 493/10 Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/340,367 14.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002351340

3 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351341-Treatment of neurodegenerative and cardiovascular disorders

2002351339-System and method for assigning call priority based on the call destination